T Narita
Overview
Explore the profile of T Narita including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
262
Citations
1715
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nakagawa K, Inami T, Yonezu T, Kenmotsu Y, Narita T, Kawakami Y, et al.
Scand J Med Sci Sports
. 2017 May;
28(2):621-629.
PMID: 28513880
We recently reported that wearing unstable rocker shoes (Masai Barefoot Technology: MBT) may enhance recovery from marathon race-induced fatigue. However, this earlier study only utilized a questionnaire. In this study,...
2.
Oikawa M, Hatakeyama S, Narita T, Yamamoto H, Hosogoe S, Imai A, et al.
Transplant Proc
. 2016 May;
48(3):701-5.
PMID: 27234717
Background: We evaluated the safety and feasibility of living kidney transplantation from marginal donors. Patients And Methods: Between June 2006 and March 2015, we performed 61 living related renal transplantations...
3.
Narita T, Ri M, Masaki A, Mori F, Ito A, Kusumoto S, et al.
Blood Cancer J
. 2015 Dec;
5:e373.
PMID: 26636288
Bortezomib (BTZ), a proteasome inhibitor, is widely used in the treatment of multiple myeloma (MM), but a fraction of patients respond poorly to this agent. To identify factors predicting the...
4.
Narita T, Inagaki A, Kobayashi T, Kuroda Y, Fukushima T, Nezu M, et al.
Blood Cancer J
. 2015 Feb;
5:e285.
PMID: 25723856
No abstract available.
5.
Sato T, Yoneyama T, Hagiwara K, Narita T, Noro D, Tanaka T, et al.
Transplant Proc
. 2014 Mar;
46(2):634-6.
PMID: 24656032
A 37-year-old man undertook preoperative examination for donor nephrectomy for living kidney transplantation. Computerized tomography revealed a small renal mass (1.9 cm in diameter) with contrast enhancement on his left...
6.
Oikawa M, Hatakeyama S, Fujita T, Murakami R, Hagiwara K, Narita T, et al.
Transplant Proc
. 2014 Mar;
46(2):616-9.
PMID: 24656027
Background: Urothelial carcinomas of ureter grafts in renal transplant patients are rare. Here we report our experience with a case of BK virus-associated urothelial carcinoma in a ureter graft. Case...
7.
Ri M, Tashiro E, Oikawa D, Shinjo S, Tokuda M, Yokouchi Y, et al.
Blood Cancer J
. 2012 Aug;
2(7):e79.
PMID: 22852048
The IRE1α-XBP1 pathway, a key component of the endoplasmic reticulum (ER) stress response, is considered to be a critical regulator for survival of multiple myeloma (MM) cells. Therefore, the availability...
8.
Narita T, Yokoyama H, Yamashita R, Sato T, Hosoba M, Morii T, et al.
Diabetes Obes Metab
. 2011 Nov;
14(3):283-7.
PMID: 22051162
To compare the effects of miglitol [an alpha-glucosidase inhibitor (AGI) absorbed in the intestine] and voglibose (an AGI not absorbed) on plasma glucagon-like peptide-1 (GLP-1) and gastric inhibitory polypeptide (GIP)...
9.
Warrington S, Lee C, Otabe A, Narita T, Polnjak O, Pirags V, et al.
Food Chem Toxicol
. 2011 Nov;
49 Suppl 1:S77-83.
PMID: 22036029
Advantame, a new, high-intensity sweetener that is thought not to be absorbed from the human gastrointestinal tract in appreciable quantities, was evaluated for safety and tolerability in a total of...
10.
Narita T, Funahashi H, Imai T, Takagi H, Kannagi R
Oncol Rep
. 2011 May;
1(4):747-50.
PMID: 21607434
Cytokeratin 19 is a subunit of cytokeratin intermediate filament. CYFRA 21-1 is a new tumor marker using monoclonal antibodies which recognize a fragment of cytokeratin 19. CYFRA 21-1 was measured...